Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
908 Devices Inc(MASS)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for MASS
10/30/2026: MASS (2-star) has a low Upturn Star Rating. Not recommended to BUY.
908 Devices is a life science and analytical technology company known for miniaturizing complex mass spectrometry devices for use in field-safety and bioprocessing environments. Its core strengths include a unique, defendable technology platform and a growing presence in biopharmaceutical manufacturing. The company's primary growth opportunity centers on the wider adoption of its desktop analyzers as integral tools for real-time bioprocessing. However, investors face risks from high cash burn, customer concentration in government sectors, and intense competition from large, well-capitalized incumbents. The stock is best suited for growth-oriented investors who can tolerate volatility and are monitoring the company's progress toward achieving sustained operational profitability.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company operates in high-growth niches of the life science and field-safety tools market. |
| Momentum investor | Mixed fit | Performance is highly conditional on product adoption rates and market cycles. |
| Value investor | Weak fit | The company is not currently focused on earnings-based valuation metrics. |
| Dividend investor | Weak fit | The company does not pay dividends and prioritizes capital reinvestment. |
| Low-risk investor | Weak fit | The stock carries significant operational and execution risks common to growth-stage technology firms. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | As a smaller growth company, the stock price is susceptible to sharp fluctuations based on sector sentiment. |
| Valuation risk | Medium / high | High valuations are often attached to growth prospects that may take time to materialize. |
| Competition risk (Large cap conglomerates) | High | Incumbent players have more resources to bundle products and defend their market share. |
| Business quality | Medium | The company has a strong niche technology but is still maturing in terms of scale and profitability. |
| Dividend income | Low / none | The company does not generate income for shareholders. |
| Execution risk | Medium / high | Successfully scaling commercial operations remains a key challenge for management. |
Price Behavior
Hockey-Stick Growth
The stock demonstrates a Hockey-Stick Growth price path pattern.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit 3.45% | Avg. Invested days 26 | Today’s Advisory WEAK BUY |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/30/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 465.00M USD | Price to earnings Ratio - | 1Y Target Price 13.38 |
Price to earnings Ratio - | 1Y Target Price 13.38 | ||
Volume (30-day avg) 370.1K shares | Beta 0.62 | 52 Weeks Range 5.03 - 13.35 | Updated Date 11/01/2026 |
52 Weeks Range 5.03 - 13.35 | Updated Date 11/01/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.94 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Handheld Devices | MX908 sales and associated service contracts for first responders. | The company earns revenue from tactical equipment sales to government agencies. |
| Desktop Devices | REBEL analyzers and recurring revenue from consumables used in bioprocessing. | Long-term growth is tied to the recurring use of the company's devices in drug development. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE - | Enterprise Value 367.77M | Price to Sales(TTM) 7.64 |
Enterprise Value 367.77M | Price to Sales(TTM) 7.64 | ||
Enterprise Value to Revenue 6.04 | Enterprise Value to EBITDA -3.15 | Shares Outstanding 41.33M | Shares Floating 28.07M |
Shares Outstanding 41.33M | Shares Floating 28.07M | ||
Percent Insiders 7.45 | Percent Institutions 84.55 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.